Rahil Dahlén

Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy

L. Öhman, M. Magnusson, K. Ung, 2015, Scandinavian journal of gastroenterology.

Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update

K. Blennow, H. Zetterberg, E. Portelius, 2017, Expert review of proteomics.

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer’s disease

W. M. van der Flier, K. Blennow, P. Scheltens, 2017, Scientific Reports.

CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis

L. Öhman, M. Simrén, M. Magnusson, 2013, United European gastroenterology journal.

Infliximab Inhibits Activation and Effector Functions of Peripheral Blood T Cells in vitro from Patients with Clinically Active Ulcerative Colitis

L. Öhman, M. Simrén, M. Magnusson, 2013, Scandinavian journal of immunology.

Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases

K. Blennow, H. Zetterberg, E. Portelius, 2018, Journal of neurochemistry.

Serum IL-17A in Newly Diagnosed Treatment-Naive Patients with Ulcerative Colitis Reflects Clinical Disease Severity and Predicts the Course of Disease

L. Öhman, L. Van Oudenhove, M. Simrén, 2013, Inflammatory bowel diseases.